Design and generation of recombinant rabies virus vectors

被引:0
|
作者
Fumitaka Osakada
Edward M Callaway
机构
[1] Systems Neurobiology Laboratories,
[2] The Salk Institute for Biological Studies,undefined
来源
Nature Protocols | 2013年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Rabies viruses, negative-strand RNA viruses, infect neurons through axon terminals and spread trans-synaptically in a retrograde direction between neurons. Rabies viruses whose glycoprotein (G) gene is deleted from the genome cannot spread across synapses. Complementation of G in trans, however, enables trans-synaptic spreading of G-deleted rabies viruses to directly connected, presynaptic neurons. Recombinant rabies viruses can encode genes of interest for labeling cells, controlling gene expression and monitoring or manipulating neural activity. Cre-dependent or bridge protein–mediated transduction and single-cell electroporation via the EnvA-TVA or EnvB-TVB (envelope glycoprotein and its specific receptor for avian sarcoma leukosis virus subgroup A or B) system allow cell type–specific or single cell–specific targeting. These rabies virus–based approaches permit the linking of connectivity to cell morphology and circuit function for particular cell types or single cells. Here we describe methods for construction of rabies viral vectors, recovery of G-deleted rabies viruses from cDNA, amplification of the viruses, pseudotyping them with EnvA or EnvB and concentration and titration of the viruses. The entire protocol takes 6–8 weeks.
引用
收藏
页码:1583 / 1601
页数:18
相关论文
共 50 条
  • [21] A New Rabies Vaccine Based on a Recombinant Orf Virus (Parapoxvirus) Expressing the Rabies Virus Glycoprotein
    Amann, Ralf
    Rohde, Joerg
    Wulle, Ulrich
    Conlee, Douglas
    Raue, Rudiger
    Martinon, Olivier
    Rziha, Hanns-Joachim
    JOURNAL OF VIROLOGY, 2013, 87 (03) : 1618 - 1630
  • [22] A Novel Rabies Vaccine Based on a Recombinant Parainfluenza Virus 5 Expressing Rabies Virus Glycoprotein
    Chen, Zhenhai
    Zhou, Ming
    Gao, Xiudan
    Zhang, Guoqing
    Ren, Guiping
    Gnanadurai, Clement W.
    Fu, Zhen F.
    He, Biao
    JOURNAL OF VIROLOGY, 2013, 87 (06) : 2986 - 2993
  • [23] A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
    Foley, HD
    McGettigan, LP
    Siler, CA
    Dietzschold, B
    Schnell, MJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) : 14680 - 14685
  • [24] Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus
    Faber, Milosz
    Li, Jianwei
    Kean, Rhonda B.
    Hooper, D. Craig
    Alugupalli, Kishore R.
    Dietzschold, Bernhard
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) : 11300 - 11305
  • [25] IMMUNIZATION OF FOXES AGAINST RABIES WITH A VACCINIA RECOMBINANT VIRUS EXPRESSING THE RABIES GLYCOPROTEIN
    TOLSON, ND
    CHARLTON, KM
    CASEY, GA
    KNOWLES, MK
    RUPPRECHT, CE
    LAWSON, KF
    CAMPBELL, JB
    ARCHIVES OF VIROLOGY, 1988, 102 (3-4) : 297 - 301
  • [26] IMMUNIZATION AGAINST RABIES USING A RECOMBINANT VACCINIA VIRUS EXPRESSING THE RABIES GLYCOPROTEIN
    LATHE, R
    KIENY, MP
    DRILLIEN, R
    LECOCQ, JP
    WIKTOR, TJ
    MACFARLAN, RI
    KOPROWSKI, H
    GENETICAL RESEARCH, 1985, 45 (02) : 213 - 213
  • [27] USE OF A VACCINIA RABIES RECOMBINANT VIRUS FOR THE ORAL VACCINATION OF FOXES AGAINST RABIES
    BROCHIER, B
    THOMAS, I
    BAUDUIN, B
    LEVEAU, T
    PASTORET, PP
    LANGUET, B
    CHAPPUIS, G
    DESMETTRE, P
    BLANCOU, J
    ARTOIS, M
    VACCINE, 1990, 8 (02) : 101 - 104
  • [28] VECTORS OF RABIES
    BOULGER, LR
    NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (18): : 1020 - &
  • [29] Generation and characterization of chimeric recombinant AAV vectors
    Hauck, B
    Chen, L
    Xiao, WD
    MOLECULAR THERAPY, 2003, 7 (03) : 419 - 425
  • [30] Generation of lentivirus vectors using recombinant baculoviruses
    Lesch, H. P.
    Turpeinen, S.
    Niskanen, E. A.
    Mahonen, A. J.
    Airenne, K. J.
    Yia -Herttuala, S.
    GENE THERAPY, 2008, 15 (18) : 1280 - 1286